Suppr超能文献

通过表达牛乳头瘤病毒 1 型 E2 蛋白靶向人乳头瘤病毒 E6 和 E7 癌基因可刺激细胞迁移。

Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.

机构信息

Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center and University of Cincinnati,College of Medicine, Cincinnati, OH 45229, USA.

出版信息

J Virol. 2011 Oct;85(20):10487-98. doi: 10.1128/JVI.05126-11. Epub 2011 Aug 10.

Abstract

Expression of the high-risk human papillomavirus (HPV) E6 and E7 oncogenes is essential for the initiation and maintenance of cervical cancer. The repression of both was previously shown to result in activation of their respective tumor suppressor targets, p53 and pRb, and subsequent senescence induction in cervical cancer cells. Consequently, viral oncogene suppression is a promising approach for the treatment of HPV-positive tumors. One well-established method of E6/E7 repression involves the reexpression of the viral E2 protein which is usually deleted in HPV-positive cancer cells. Here, we show that, surprisingly, bovine papillomavirus type 1 (BPV1) E2 but not RNA interference-mediated E6/E7 repression in HPV-positive cervical cancer cells stimulates cellular motility and invasion. Migration correlated with the dynamic formation of cellular protrusions and was dependent upon cell-to-cell contact. While E2-expressing migratory cells were senescent, migration was not a general feature of cellular senescence or cell cycle arrest and was specifically observed in HPV-positive cervical cancer cells. Interestingly, E2-expressing cells not only were themselves motile but also conferred increased motility to admixed HeLa cervical cancer cells. Together, our data suggest that repression of the viral oncogenes by E2 stimulates the motility of E6/E7-targeted cells as well as adjacent nontargeted cancer cells, thus raising the possibility that E2 expression may unfavorably increase the local invasiveness of HPV-positive tumors.

摘要

高危型人乳头瘤病毒(HPV)E6 和 E7 癌基因的表达对于宫颈癌的发生和维持至关重要。先前的研究表明,这两种基因的抑制会导致其各自的肿瘤抑制靶标 p53 和 pRb 的激活,随后导致宫颈癌细胞衰老。因此,抑制病毒癌基因是治疗 HPV 阳性肿瘤的一种很有前途的方法。一种已被广泛证实的 E6/E7 抑制方法涉及病毒 E2 蛋白的重新表达,而 HPV 阳性癌细胞中通常会缺失 E2 蛋白。在这里,我们惊讶地发现,牛乳头瘤病毒 1 型(BPV1)E2 而不是 HPV 阳性宫颈癌细胞中 RNA 干扰介导的 E6/E7 抑制会刺激细胞迁移和侵袭。迁移与细胞突起的动态形成相关,并依赖于细胞间接触。虽然表达 E2 的迁移细胞衰老,但迁移不是细胞衰老或细胞周期停滞的一般特征,而是在 HPV 阳性宫颈癌细胞中特异性观察到的。有趣的是,表达 E2 的细胞不仅本身具有迁移性,而且还赋予混合的 HeLa 宫颈癌细胞更高的迁移性。总之,我们的数据表明,E2 对病毒癌基因的抑制会刺激 E6/E7 靶向细胞以及相邻的非靶向癌细胞的迁移性,从而增加了 E2 表达可能不利地增加 HPV 阳性肿瘤局部侵袭性的可能性。

相似文献

8
10
Suppression of cellular proliferation by the papillomavirus E2 protein.
J Virol. 1995 Dec;69(12):7791-9. doi: 10.1128/JVI.69.12.7791-7799.1995.

引用本文的文献

1
Fibroblasts regulate the transcriptional signature of human papillomavirus-positive keratinocytes.
Tumour Virus Res. 2024 Dec 10;19:200302. doi: 10.1016/j.tvr.2024.200302.
2
Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer.
bioRxiv. 2024 Oct 17:2024.10.17.618959. doi: 10.1101/2024.10.17.618959.
3
Fibroblasts Regulate the Transformation Potential of Human Papillomavirus-positive Keratinocytes.
bioRxiv. 2024 Sep 21:2024.09.16.613347. doi: 10.1101/2024.09.16.613347.
4
Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.
mSphere. 2020 Mar 18;5(2):e00049-20. doi: 10.1128/mSphere.00049-20.
5
Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.
J Cancer Res Clin Oncol. 2016 Nov;142(11):2367-73. doi: 10.1007/s00432-016-2227-z. Epub 2016 Aug 30.
8
Regulation of human genome expression and RNA splicing by human papillomavirus 16 E2 protein.
Virology. 2014 Nov;468-470:10-18. doi: 10.1016/j.virol.2014.07.022. Epub 2014 Aug 16.
10
Photon-induced cell migration and integrin expression promoted by DNA integration of HPV16 genome.
Strahlenther Onkol. 2014 Oct;190(10):944-9. doi: 10.1007/s00066-014-0649-6. Epub 2014 Mar 19.

本文引用的文献

1
Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells.
Med Oncol. 2011 Dec;28 Suppl 1:S528-39. doi: 10.1007/s12032-010-9690-1. Epub 2011 Jan 11.
4
Human papillomavirus oncoproteins: pathways to transformation.
Nat Rev Cancer. 2010 Aug;10(8):550-60. doi: 10.1038/nrc2886. Epub 2010 Jul 1.
6
HPV E6 protein interacts physically and functionally with the cellular telomerase complex.
Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18780-5. doi: 10.1073/pnas.0906357106. Epub 2009 Oct 20.
8
E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
J Natl Cancer Inst. 2009 Mar 18;101(6):412-23. doi: 10.1093/jnci/djp017. Epub 2009 Mar 10.
9
Senescence induction; a possible cancer therapy.
Mol Cancer. 2009 Jan 8;8:3. doi: 10.1186/1476-4598-8-3.
10
Human papillomaviruses, cervical cancer and cell polarity.
Oncogene. 2008 Nov 24;27(55):7018-30. doi: 10.1038/onc.2008.351.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验